Literature DB >> 19789361

Predominance of adenosine excitatory over inhibitory effects on transmission at the neuromuscular junction of infant rats.

Paula A Pousinha1, Alexandra M Correia, Ana M Sebastião, Joaquim A Ribeiro.   

Abstract

Adenosine-induced modulation of neuromuscular transmission in young (3-4-week-old) rats was evaluated. Inhibition of adenosine kinase with iodotubercidin (ITU; 10 microM), which is known to induce adenosine release, enhanced the amplitude of evoked end-plate potentials (EPPs) recorded from innervated diaphragm muscle fibers. This facilitatory effect was transformed into an inhibitory one upon blockade of adenosine A(2A) receptors with 4-(2-[7-amino-2-(2-furly)[1,2,4]triazolo[2,3-a][1,3,5]triazin5ylamino] ethyl) phenol (ZM 241385) (50 nM); further blockade of adenosine A(1) receptors with the selective antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; 10 nM) abolished that inhibition. Adenosine or 2-chloroadenosine (CADO), at submicromolar concentrations, increased the amplitude and the quantal content of EPPs, whereas at low micromolar concentrations they decreased EPP amplitude. Blockade of A(1) receptors with DPCPX (10 nM) prevented both excitatory and inhibitory effects, whereas blockade of A(2A) receptors with ZM241385 (50 nM) prevented only the excitatory effects. DPCPX and ZM241385 also prevented the excitatory effect of the selective A(2A) receptor agonist 2-[p-(2-carboxyethyl) phenethylamino]-5'-N-ethylcarboxamido adenosine hydrochloride (CGS 21680; 10 nM). CADO (30 nM) also increased neuromuscular transmission in adult (12-16-week-old) rats. It is suggested that at the motor nerve endings, low extracellular concentrations of adenosine activate both A(2A) and A(1) receptors, but activation of A(2A) receptors predominates over A(1) receptors; the activity of A(2A) receptors might, however, require coactivation of A(1) receptors. This facilitatory action of low concentrations of extracellular adenosine upon acetylcholine release may be particularly relevant at developing neuromuscular junctions, where subtle changes in synaptic levels of acetylcholine might influence synaptic stabilization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789361     DOI: 10.1124/jpet.109.157255

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

2.  Adenosine A2B and A3 receptor location at the mouse neuromuscular junction.

Authors:  Neus Garcia; Mercedes Priego; Erica Hurtado; Teresa Obis; Manel M Santafe; Marta Tomàs; Maria Angel Lanuza; Josep Tomàs
Journal:  J Anat       Date:  2014-04-23       Impact factor: 2.610

3.  Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.

Authors:  Filipe Nascimento; Ana M Sebastião; Joaquim A Ribeiro
Journal:  Purinergic Signal       Date:  2015-09-03       Impact factor: 3.765

4.  Effects of presynaptic muscarinic cholinoreceptor blockade on neuromuscular transmission as assessed by the train-of-four and the tetanic fade response to rocuronium.

Authors:  Yong Beom Kim; Sangseok Lee; Kyeong Chun Lee; Ha Jung Kim; Young Jin Ro; Hong-Seuk Yang
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-07       Impact factor: 2.557

5.  Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase.

Authors:  Filipe Nascimento; Paula A Pousinha; Alexandra M Correia; Rui Gomes; Ana M Sebastião; Joaquim A Ribeiro
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

6.  Presynaptic muscarinic acetylcholine autoreceptors (M1, M2 and M4 subtypes), adenosine receptors (A1 and A2A) and tropomyosin-related kinase B receptor (TrkB) modulate the developmental synapse elimination process at the neuromuscular junction.

Authors:  Laura Nadal; Neus Garcia; Erica Hurtado; Anna Simó; Marta Tomàs; Maria A Lanuza; Manel Santafé; Josep Tomàs
Journal:  Mol Brain       Date:  2016-06-23       Impact factor: 4.041

7.  Adenosine Receptors in Developing and Adult Mouse Neuromuscular Junctions and Functional Links With Other Metabotropic Receptor Pathways.

Authors:  Josep Tomàs; Neus Garcia; Maria A Lanuza; Manel M Santafé; Marta Tomàs; Laura Nadal; Erica Hurtado; Anna Simó-Ollé; Víctor Cilleros-Mañé; Laia Just-Borràs
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

Review 8.  Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.

Authors:  Ana M Sebastião; Nádia Rei; Joaquim A Ribeiro
Journal:  Front Pharmacol       Date:  2018-04-16       Impact factor: 5.810

9.  Effects of adenosine receptor agonist on the rocuroniuminduced neuromuscular block and sugammadex-induced recovery.

Authors:  Yong Beom Kim; Sangseok Lee; Hey Ran Choi; Junyong In; Young Jin Chang; Ha Jung Kim; Young Jin Ro; Hong-Seuk Yang
Journal:  Korean J Anesthesiol       Date:  2018-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.